2024
Two years' experience with the Czech population pilot programme for lung cancer early detection
HEJDUK, Karel; Martina KOZIAR-VASAKOVA; Ivana CIERNA-PETEROVA; Hynek MIRKA; Bohumil SEIFERT et. al.Základní údaje
Originální název
Two years' experience with the Czech population pilot programme for lung cancer early detection
Autoři
HEJDUK, Karel; Martina KOZIAR-VASAKOVA; Ivana CIERNA-PETEROVA; Hynek MIRKA; Bohumil SEIFERT; Jana SKRICKOVA; Vladimir KOBLIZEK; Alena MENSIKOV; Marcela KOUDELKOVA; Renata CHLOUPKOVA; Ondrej NGO; Nikola STOURAC a Ondrej MAJEK
Vydání
ERS Congress 2024 7.-11.9.2024 Vienna, 2024
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
30230 Other clinical medicine subjects
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 21.000
Kód RIV
RIV/00216224:14110/24:00138351
Organizační jednotka
Lékařská fakulta
ISSN
UT WoS
001361501200090
Klíčová slova česky
lung cancer; low-dose CT; LDCT; clinical trial
Klíčová slova anglicky
lung cancer; low-dose CT; LDCT; clinical trial
Příznaky
Mezinárodní význam
Změněno: 4. 4. 2025 13:59, Bc. Hana Vladíková, BBA
Anotace
V originále
The Czech population pilot programme for lung cancer early detection was initiated in 2022. Target population comprises men and women aged 55–74 years with smoking history (at least 20 pack-years), former of current smokers. The estimated number of persons meeting the criteria is 250,000 to 500,000. GPs offer the programme and refer participants to a pneumologist, individuals can also contact their pneumologist directly. Pneumologists perform complex pulmonary examinations, refer patients for low-dose CT (LDCT) and navigate them in the healthcare system. LDCT is provided only at radiological departments certified by the Ministry of Health. The programme uses LDCT, initially repeated after one year, then after 2 years. The results of two years of project implementation show that over 20,000 people underwent initial risk assessment (77 % by GPs, 13 % by pneumologist), 10,000 people underwent lung examinations, and first LDCT was performed in 6,500 people. On the basis of the first LDCT examination (or the repeated LDCT examination after an indeterminate result), the majority of patients (89%) were negative. Almost 8% of subjects had an indeterminate result and almost 4% of subjects were positive; those patients were referred to specialized pneumo-onco-surgical centres. The Czech programme has been successfully initiated and is now undergoing continuous monitoring. Estimated process characteristics are in line with expectations from clinical trials.
Návaznosti
| 90249, velká výzkumná infrastruktura |
|